Positive results of preclinical studies confirm the potential of Neurizon’s lead drug candidate NUZ-001 to be a ...

I pray that she carries the love that she felt tonight every day that she has," said friend Rita Monteiro, who organized the ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

Report Ocean has published a new report on the Amyotrophic Lateral Sclerosis (ALS) Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Zac Brown Band's John Driskell Hopkins is turning his battle with ALS into a mission to help others: "When you're given a ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...

In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...

Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...